We are fully committed to doing all that we can to get vaccines out to poorer countries, but when it comes to delivery, there are three different issues. The first is supply, the second is the need to ensure that the local health services are able to deliver the vaccine, and the third is, sadly, the very serious issue of vaccine hesitancy in many countries. COVAX did experience severe challenges in obtaining vaccine supplies owing to export bans, but supplies are now increasing. We in the UK have already delivered 16.1 million doses through COVAX, an additional 9 million AstraZeneca doses will be sent out in the coming weeks, and, most recently, we delivered 5.2 million doses to the Philippines last Saturday.

The UK is engaging intensively and constructively in the trade-related intellectual property rights—TRIPS—waiver debate, but in the meantime we must continue to push ahead with pragmatic action. For example, we have sent UK emergency medical teams to 11 African countries, where they are providing training and advice for health workers in respect of issues including vaccine confidence.